EGFR and head and neck squamous cell carcinoma: For instance, in HNSCC, TDEs containing oncogenic EGFR are taken up by endothelial cells both in vitro and in vivo, activating the autocrine VEGF/VEGFR-2 pathway to induce angiogenesis [45] (Figure 1B).